| Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
|---|---|---|---|---|---|---|---|---|
 Filter
|
Homo sapiens
|
Michael Hecker
|
||||||
| GSE19285 |
Expression data of multiple sclerosis patients receiving intramuscular Interferon-beta-1a therapy [U133 A and B]
|
|
144 | Michael Hecker | Dec 03, 2009 | |||
| GSE33464 |
Expression data of multiple sclerosis patients receiving subcutaneous Interferon-beta-1a therapy [U133 Plus 2.0]
|
|
60 | Michael Hecker | Dec 06, 2011 | |||
| GSE42763 |
Expression data of multiple sclerosis patients receiving glatiramer acetate therapy [U133 Plus 2.0]
|
|
37 | Michael Hecker | Dec 07, 2012 | |||
| GSE46280 |
Expression data of multiple sclerosis patients receiving Interferon-beta therapy [HG-U133_Plus_2]
|
|
24 | Michael Hecker | Apr 24, 2013 | |||
| GSE46282 |
Expression data of multiple sclerosis patients receiving Interferon-beta therapy [miRNA-2_0]
|
|
6 | Michael Hecker | Apr 24, 2013 | |||
| GSE46283 |
Expression data of multiple sclerosis patients receiving Interferon-beta therapy [TaqMan(r) Array Human MicroRNA A Cards v2.0]
|
|
24 | Michael Hecker | Apr 24, 2013 | |||
| GSE46292 |
Expression data of multiple sclerosis patients receiving Interferon-beta therapy [TaqMan(r) Array Human MicroRNA B Cards v2.0]
|
|
24 | Michael Hecker | Apr 24, 2013 | |||
| GSE46293 |
Expression data of multiple sclerosis patients receiving Interferon-beta therapy
|
|
78 | Michael Hecker | Apr 24, 2013 | |||
| GSE73079 |
Transcriptome data of multiple sclerosis patients receiving fingolimod therapy [HTA-2_0, CD4+ cells, gene level]
|
|
30 | Michael Hecker | Sep 19, 2015 | |||
| GSE73080 |
Transcriptome data of multiple sclerosis patients receiving fingolimod therapy [HTA-2_0, CD4+ cells, exon level]
|
|
30 | Michael Hecker | Sep 19, 2015 | |||
| GSE73081 |
Transcriptome data of multiple sclerosis patients receiving fingolimod therapy [HTA-2_0, CD8+ cells, gene level]
|
|
30 | Michael Hecker | Sep 19, 2015 | |||
| GSE73172 |
Transcriptome data of multiple sclerosis patients receiving fingolimod therapy [HTA-2_0, CD8+ cells, exon level]
|
|
30 | Michael Hecker | Sep 19, 2015 | |||
| GSE73174 |
Transcriptome data of multiple sclerosis patients receiving fingolimod therapy
|
|
300 | Michael Hecker | Sep 19, 2015 | |||
| GSE81598 |
Transcriptome data of multiple sclerosis patients receiving fingolimod therapy [HTA-2_0, CD14+ cells, gene level]
|
|
30 | Michael Hecker | May 20, 2016 | |||
| GSE81603 |
Transcriptome data of multiple sclerosis patients receiving fingolimod therapy [HTA-2_0, CD14+ cells, exon level]
|
|
30 | Michael Hecker | May 20, 2016 | |||
| GSE81604 |
Transcriptome data of multiple sclerosis patients receiving fingolimod therapy [HTA-2_0, CD19+ cells, gene level]
|
|
30 | Michael Hecker | May 20, 2016 | |||
| GSE81606 |
Transcriptome data of multiple sclerosis patients receiving fingolimod therapy [HTA-2_0, CD19+ cells, exon level]
|
|
30 | Michael Hecker | May 20, 2016 | |||
| GSE81607 |
Transcriptome data of multiple sclerosis patients receiving fingolimod therapy [HTA-2_0, CD56+ cells, gene level]
|
|
30 | Michael Hecker | May 20, 2016 | |||
| GSE81611 |
Transcriptome data of multiple sclerosis patients receiving fingolimod therapy [HTA-2_0, CD56+ cells, exon level]
|
|
30 | Michael Hecker | May 20, 2016 | |||
| GSE120769 |
Screening for potential target genes of microRNA-548ac using HTA 2.0 microarrays
|
|
10 | Michael Hecker | Oct 03, 2018 |
